150 related articles for article (PubMed ID: 38100967)
1. Tetrahydrobiopterin inhibitor-based antioxidant metabolic strategy for enhanced cancer ferroptosis-immunotherapy.
Liu Z; Kang R; Yang N; Pan X; Yang J; Yu H; Deng W; Jia Z; Zhang J; Shen Q
J Colloid Interface Sci; 2024 Mar; 658():100-113. PubMed ID: 38100967
[TBL] [Abstract][Full Text] [Related]
2. Fe-MnO
Huang D; Xu D; Chen W; Wu R; Wen Y; Liu A; Lin L; Lin X; Wang X
Biomed Pharmacother; 2023 May; 161():114431. PubMed ID: 36827713
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy-mediated redox homeostasis-controllable nanomedicine for enhanced ferroptosis sensitivity in tumor therapy.
Lin Y; Chen X; Yu C; Xu G; Nie X; Cheng Y; Luan Y; Song Q
Acta Biomater; 2023 Mar; 159():300-311. PubMed ID: 36642338
[TBL] [Abstract][Full Text] [Related]
4. Ultrathin Clay Nanoparticles-Mediated Mutual Reinforcement of Ferroptosis and Cancer Immunotherapy.
Liu J; Zhan J; Zhang Y; Huang L; Yang J; Feng J; Ding L; Shen Z; Chen X
Adv Mater; 2024 Mar; 36(9):e2309562. PubMed ID: 37939375
[TBL] [Abstract][Full Text] [Related]
5. Biomimetic Nanoarchitectonics with Chitosan Nanogels for Collaborative Induction of Ferroptosis and Anticancer Immunity for Cancer Therapy.
Yang N; Pan X; Zhou X; Liu Z; Yang J; Zhang J; Jia Z; Shen Q
Adv Healthc Mater; 2024 Mar; 13(7):e2302752. PubMed ID: 37975280
[TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitor-enhanced nanocatalytic ferroptosis induction for stimuli-responsive dual-modal molecular imaging guided cancer radiosensitization.
Zheng S; Hu H; Hou M; Zhu K; Wu Z; Qi L; Xia H; Liu G; Ren Y; Xu Y; Yan C; Zhao B
Acta Biomater; 2023 May; 162():72-84. PubMed ID: 36931419
[TBL] [Abstract][Full Text] [Related]
7. A multi-mode Rhein-based nano-platform synergizing ferrotherapy/chemotherapy-induced immunotherapy for enhanced tumor therapy.
Zhu X; Xie L; Tian J; Jiang Y; Song E; Song Y
Acta Biomater; 2024 May; 180():383-393. PubMed ID: 38570106
[TBL] [Abstract][Full Text] [Related]
8. Blockade of GCH1/BH4 Axis Activates Ferritinophagy to Mitigate the Resistance of Colorectal Cancer to Erastin-Induced Ferroptosis.
Hu Q; Wei W; Wu D; Huang F; Li M; Li W; Yin J; Peng Y; Lu Y; Zhao Q; Liu L
Front Cell Dev Biol; 2022; 10():810327. PubMed ID: 35223839
[TBL] [Abstract][Full Text] [Related]
9. Synergistic Functional Nanomedicine Enhances Ferroptosis Therapy for Breast Tumors by a Blocking Defensive Redox System.
Chen S; Yang J; Liang Z; Li Z; Xiong W; Fan Q; Shen Z; Liu J; Xu Y
ACS Appl Mater Interfaces; 2023 Jan; 15(2):2705-2713. PubMed ID: 36622364
[TBL] [Abstract][Full Text] [Related]
10. Engineering a synergistic antioxidant inhibition nanoplatform to enhance oxidative damage in tumor treatment.
Zhang Q; Sun Z; Sun W; Yu B; Liu J; Jiang C; Lu L
Acta Biomater; 2023 Mar; 158():625-636. PubMed ID: 36608895
[TBL] [Abstract][Full Text] [Related]
11. An all-in-one biomimetic iron-small interfering RNA nanoplatform induces ferroptosis for cancer therapy.
Huang S; Le H; Hong G; Chen G; Zhang F; Lu L; Zhang X; Qiu Y; Wang Z; Zhang Q; Ouyang G; Shen J
Acta Biomater; 2022 Aug; 148():244-257. PubMed ID: 35709941
[TBL] [Abstract][Full Text] [Related]
12. Spatially Asymmetric Nanoparticles for Boosting Ferroptosis in Tumor Therapy.
Hou M; Liu M; Yu H; Kou Y; Jia J; Zhou Q; Zhang F; Zhao D; Zhao T; Li X
Nano Lett; 2024 Jan; 24(4):1284-1293. PubMed ID: 38230643
[TBL] [Abstract][Full Text] [Related]
13. Tetrahydrobiopterin metabolism attenuates ROS generation and radiosensitivity through LDHA S-nitrosylation: novel insight into radiogenic lung injury.
Feng Y; Feng Y; Gu L; Mo W; Wang X; Song B; Hong M; Geng F; Huang P; Yang H; Zhu W; Jiao Y; Zhang Q; Ding WQ; Cao J; Zhang S
Exp Mol Med; 2024 May; 56(5):1107-1122. PubMed ID: 38689083
[TBL] [Abstract][Full Text] [Related]
14. GTP Cyclohydrolase 1/Tetrahydrobiopterin Counteract Ferroptosis through Lipid Remodeling.
Kraft VAN; Bezjian CT; Pfeiffer S; Ringelstetter L; Müller C; Zandkarimi F; Merl-Pham J; Bao X; Anastasov N; Kössl J; Brandner S; Daniels JD; Schmitt-Kopplin P; Hauck SM; Stockwell BR; Hadian K; Schick JA
ACS Cent Sci; 2020 Jan; 6(1):41-53. PubMed ID: 31989025
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound (US)-activated redox dyshomeostasis therapy reinforced by immunogenic cell death (ICD) through a mitochondrial targeting liposomal nanosystem.
Ren J; Zhou J; Liu H; Jiao X; Cao Y; Xu Z; Kang Y; Xue P
Theranostics; 2021; 11(19):9470-9491. PubMed ID: 34646381
[No Abstract] [Full Text] [Related]
16. Combination of ferroptosis and pyroptosis dual induction by triptolide nano-MOFs for immunotherapy of Melanoma.
Wang S; Guo Q; Xu R; Lin P; Deng G; Xia X
J Nanobiotechnology; 2023 Oct; 21(1):383. PubMed ID: 37858186
[TBL] [Abstract][Full Text] [Related]
17. Inhalable Biomineralized Liposomes for Cyclic Ca
Fu F; Wang W; Wu L; Wang W; Huang Z; Huang Y; Wu C; Pan X
ACS Nano; 2023 Mar; 17(6):5486-5502. PubMed ID: 36883602
[TBL] [Abstract][Full Text] [Related]
18. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy.
Zhang Z; Pan Y; Cun JE; Li J; Guo Z; Pan Q; Gao W; Pu Y; Luo K; He B
Acta Biomater; 2022 Oct; 151():480-490. PubMed ID: 35926781
[TBL] [Abstract][Full Text] [Related]
19. Three-Step Depletion Strategy of Glutathione: Tunable Metal-Organic-Framework-Engineered Nanozymes for Driving Oxidative/Nitrative Stress to Maximize Ferroptosis Therapy.
Li W; Liu S; Ding H; Zhao R; Zang P; Li S; Fang L; Li R; Zhang M; Yang P
Nano Lett; 2024 Feb; 24(6):2071-2080. PubMed ID: 38305186
[TBL] [Abstract][Full Text] [Related]
20. A Triple-Responsive Polymeric Prodrug Nanoplatform with Extracellular ROS Consumption and Intracellular H
Li Y; Cao Y; Ma K; Ma R; Zhang M; Guo Y; Song H; Sun N; Zhang Z; Yang W
Adv Healthc Mater; 2024 Feb; ():e2303568. PubMed ID: 38319010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
